Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Podcast: Mark McClellan Explains New NEST Recommendations

Executive Summary

In this interview, Mark McClellan, the Duke-Margolis Center director and health-policy expert, discusses new planning-board proposals for the National Evaluation System for health Technology, which US FDA envisions as a paradigm shift for device data collection.

Mark McClellan

Mark McClellan is the director of the Duke-Margolis Center, which is overseeing the public-private planning board that issued a new report outlining steps to launch a National Evaluation System for health Technology (NEST). (Also see "Next Steps For NEST: Planning Board Lays Out Launch Strategy For Evaluation System" - Medtech Insight, 20 Sep, 2016.).

In this interview, McClellan, who is also a former administrator of the US Center for Medicare and Medicaid Services and a former commissioner of the FDA, discusses the rationales behind the NEST program and some of the details of the planning board's recommendations.

Listen to the conversation with McClellan via the podcast player below:

From the editors of The Gray Sheet


Related Content

Next Steps For NEST: Planning Board Lays Out Launch Strategy For Evaluation System


Key Documents